Bee venom gel could soothe arthritic knees, small trial hopes
NCT ID NCT07151300
First seen Jun 24, 2026 · Last updated Aug 05, 2026 · Updated 4 times
Summary
This study tests whether applying bee venom gel to the knee during ultrasound therapy can reduce pain and improve movement in people with knee osteoarthritis. Thirty adults aged 40-75 will either get the bee venom treatment or a placebo gel. Researchers will measure pain, walking speed, and endurance to see if the bee venom approach works better than the placebo.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bee venom topical preparation
- What this could lead to
- If it works, this could offer a non-invasive, drug-free option to ease pain and improve walking in people with knee osteoarthritis.
- What could go wrong
- This is a very small, early-stage trial with only 30 people. The bee venom may cause allergic reactions, and the benefit over placebo is unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 40-75 years * Clinically and radiographically confirmed knee osteoarthritis * Moderate to severe pain (VAS ≥ 4) * Willingness to provide informed consent Exclusion Criteria: * Allergy to bee products or topical agents used in the study * Knee surgery or trauma in the past year * Intra-articular injection in the past 6 months * Other musculoskeletal or systemic conditions affecting the knees (e.g., rheumatoid arthritis) * Pregnancy or contraindication to ultrasound therapy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Knee osteoarthritis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Sinai university
Cairo, 44511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can robotic surgery personalize knee replacement?
- Custom knee guides put to the test in obese patients
- Can a shot of your own blood ease arthritic knees?
- 5,000 knee arthritis patients tracked to crack the treatment code
- Can a hydrogel injection ease knee arthritis pain?
- Weekly shot aims to melt away pounds in obesity fight